IKCS 2020: Treatment selection in kidney cancer
During this interview, Dr Rana McKay from the University of [...]
Treatment of kidney masses in patients with VHL disease
In this video interview, Dr Eric Jonasch from MD Anderson [...]
Individualising first line treatment for advanced kidney cancer
In recent years, a number of new, effective treatments have [...]
Pembrolizumab plus lenvatinib for first-line treatment of kidney cancer shows promise
Results from the phase 3 KEYNOTE-581/CLEAR trial show that the [...]
UK first in the world to launch the COVID-19 vaccine
The UK has embarked on a large-scale vaccination programme to [...]
Approach to selection of first-line treatment for advanced kidney cancer
During this online interview, the approach to selection of first-line [...]
Neoadjuvant nivolumab for patients with non-metastatic high risk kidney cancer
A recent phase 1 trial showed that treatment with nivolumab [...]
Active surveillance is a safe strategy for small renal masses suspected to be cancer
A recent study published at the 21st Annual Meeting of [...]
Psychosocial effects of kidney cancer
As with most cancers, the psychosocial effects of renal cell [...]
UK first to approve coronavirus vaccine
The UK has become the first country in the world [...]
